CHRONIC MYELOID LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients stuck in treatment deadlock
Disease control Recruiting nowThis study tests a drug called asciminib in people with chronic myeloid leukemia (CML) who have a specific genetic change (T315I mutation) that makes standard treatments less effective. The goal is to see if asciminib can control the disease and improve outcomes for about 20 part…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 00:44 UTC
-
Could bone marrow from deceased donors treat blood cancers?
Disease control Recruiting nowThis early-phase study tests whether bone marrow from deceased donors can be safely used for people with blood cancers like leukemia and lymphoma. About 12 patients will receive a transplant after chemotherapy, and doctors will monitor for side effects and blood cell recovery for…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Phase: PHASE1, PHASE2 • Sponsor: Ossium Health, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
2000 CML patients to rate their care in major italian study
Knowledge-focused Recruiting nowThis study looks at how the way hospitals organize care for chronic myeloid leukemia (CML) affects patients' quality of life. Researchers will ask 2000 adults with CML in Lombardy, Italy, to fill out questionnaires about their symptoms, daily functioning, and satisfaction with ca…
Matched conditions: CHRONIC MYELOID LEUKEMIA (CML)
Sponsor: University of Milano Bicocca • Aim: Knowledge-focused
Last updated May 17, 2026 00:51 UTC